Identification of a new aggressive axis driven by ciliogenesis and absence of VDAC1-ΔC in clear cell Renal Cell Carcinoma patients

Autor: Mazure, Nathalie M, Fabbri, Lucilla, Dufies, Maeva, Lacas-Gervais, Sandra, Gardie, Betty, Gad-Lapiteau, Sophie, Parola, Julien, Nottet, Nicolas, Meyenberg Cunha de Padua, Monique, Contenti, Julie, Borchiellini, Delphine, Ferrero, Jean-Marc, Leclercq, Nathalie Rioux, Ambrosetti, Damien, Mograbi, Baharia, Richard, Stéphane, Viotti, Julien, Chamorey, Emmanuel, Sadaghianloo, Nirvana, Rouleau, Matthieu, Craigen, William, Mari, Bernard, Clavel, Stéphan, Pagès, Gilles, Pouysségur, Jacques, Bost, Frédéric, Mazure, Nathalie

Publikováno v: Theranostics
Theranostics, Ivyspring International Publisher, 2020, 10 (6), pp.2696-2713. ⟨10.7150/thno.41001⟩
Theranostics, 2020, 10 (6), pp.2696-2713. ⟨10.7150/thno.41001⟩

International audience; Rationale: Renal cell carcinoma (RCC) accounts for about 2% of all adult cancers, and clear cell RCC (ccRCC) is the most common RCC histologic subtype. A hallmark of ccRCC is the loss of the primary cilium, a cellular antenna

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f9c43ef1acea5eae482c94bbff7a383
https://hal.archives-ouvertes.fr/hal-03034269

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Soluble CD146 is a predictive marker of pejorative evolution and of sunitinib efficacy in clear cell renal cell carcinoma

Autor: Dufies, Maeva, Nollet, Marie, Ambrosetti, Damien, Traboulsi, Wael, Viotti, Julien, Borchiellini, Delphine, Grépin, Renaud, Parola, Julien, Giuliano, Sandy, Helley-Russick, Dominique, Bensalah, Karim, Ravaud, Alain, Bernhard, Jean-Christophe, Schiappa, Renaud, Bardin, Nathalie, Dignat-George, Francoise, Rioux-Leclercq, Nathalie, Oudard, Stéphane, Négrier, Sylvie, Ferrero, Jean-Marc, Chamorey, Emmanuel, Blot-Chabaud, Marcel, Pagès, Gilles

Publikováno v: Theranostics
Theranostics, Ivyspring International Publisher, 2018, 8 (9), pp.2447-2458. ⟨10.7150/thno.23002⟩
Theranostics, 2018, 8 (9), pp.2447-2458. ⟨10.7150/thno.23002⟩
Theranostics 9 (8), 2447-2458. (2018)

International audience; The objective of the study was to use CD146 mRNA to predict the evolution of patients with non-metastatic clear cell renal cell carcinoma (M0 ccRCC) towards metastatic disease, and to use soluble CD146 (sCD146) to anticipate r

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::c504c5d91eede8cbd9454f4812d50f20
https://hal-amu.archives-ouvertes.fr/hal-02060593/document

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.